UBS Group AG current report, Q1 FY2016

Full document

UBS Group AG Form 6-K Summary: Q1 2016 Regulatory Disclosures

Business Context and Reporting Period

This Form 6-K, filed on May 3, 2016, reports consolidated regulatory information for UBS Group AG as of March 31, 2016. The filing focuses on Pillar 3 disclosures under Basel III regulations, specifically detailing the leverage ratio, the reconciliation of the IFRS balance sheet to the regulatory scope of consolidation, and the composition of regulatory capital. The document does not contain standard financial performance metrics such as revenue, net income, or operating cash flow.

Key Financial Metrics: Capital and Leverage

The filing provides detailed data on regulatory capital adequacy and leverage exposure rather than profitability.

  • BIS Basel III Leverage Ratio: 4.8% on a phase-in basis and 4.1% on a fully applied basis as of March 31, 2016.
  • Leverage Ratio Denominator (Total Exposures): CHF 910 billion (phase-in) and CHF 905.8 billion (fully applied).
  • Tier 1 Capital: CHF 43.5 billion (phase-in) and CHF 37.4 billion (fully applied).
  • Common Equity Tier 1 (CET1) Capital: CHF 36.6 billion (phase-in).
  • Total Capital: CHF 55.6 billion (phase-in).
  • Risk-Weighted Assets (RWA): CHF 216.5 billion.
  • Capital Ratios: CET1 ratio of 16.9%, Tier 1 ratio of 20.1%, and Total Capital ratio of 25.7%.
  • IFRS Total Assets: CHF 966.9 billion.

Material Changes Versus Prior Period

Comparisons are provided against the previous three quarters (Dec 31, 2015; Sept 30, 2015; June 30, 2015).

  • Leverage Ratio Trend (Phase-in): The ratio decreased slightly from 4.9% in Q4 2015 to 4.8% in Q1 2016. It had previously been 4.7% in Q3 2015 and 4.3% in Q2 2015.
  • Leverage Ratio Trend (Fully Applied): The ratio increased from 4.0% in Q4 2015 to 4.1% in Q1 2016, continuing an upward trend from 3.9% in Q3 2015 and 3.6% in Q2 2015.
  • Exposure Denominator: Total exposures (phase-in) increased from CHF 904 billion in Q4 2015 to CHF 910 billion in Q1 2016.
  • Capital Base: Tier 1 capital (phase-in) decreased from CHF 44.6 billion in Q4 2015 to CHF 43.5 billion in Q1 2016.

Guidance, Outlook, and Regulatory Composition

The filing does not contain management commentary, forward-looking guidance, or risk outlooks. It strictly presents regulatory data.

  • Capital Composition: Significant regulatory adjustments were applied to CET1 capital, totaling CHF 18.1 billion (phase-in). Major deductions included goodwill (CHF 3.8 billion), deferred tax assets recognized for tax loss carry-forwards (CHF 4.5 billion), and unrealized losses from cash flow hedges (CHF 2.2 billion).
  • Balance Sheet Reconciliation: The regulatory scope of consolidation differs from the IFRS scope. Adjustments included deconsolidating certain banking/financial entities (CHF 16.2 billion reduction in assets) and removing carrying values of derivative financial instruments (CHF 206 billion) and securities financing transactions (CHF 123 billion) from the leverage ratio denominator calculation.
  • Capital Requirements: The total capital requirement (base, buffer, and G-SIB) was 8.3% of risk-weighted assets. The bank's CET1 available to meet buffers was 17.1%.

Investor Verification Checklist

  • Verify the full Q1 2016 earnings report for revenue, profit, and cash flow data, as this filing excludes those metrics.
  • Confirm the impact of the "fully applied" leverage ratio (4.1%) versus the "phase-in" ratio (4.8%) on future capital planning.
  • Review the specific components of the CHF 18.1 billion regulatory adjustments to CET1 capital to understand the quality of the capital base.
  • Check the Swiss SRB leverage ratio separately, as this filing notes it is disclosed in the main Q1 2016 report, not this 6-K.
  • Monitor the trend in the leverage ratio denominator (exposures), which rose to CHF 910 billion, indicating potential balance sheet expansion or changes in off-balance sheet exposures.